The natural course of infantile Pompe's disease: 20 Original cases compared with 133 cases from the literature

Pediatrics

Volumn 112, Issue 2 I, 2003, Pages 332-340

  Van den Hout, Hannerieke M P ^a   Hop, Wim ^b   Van Diggelen, Otto P ^b   Smeitink, Jan A M ^c   Smit, G Peter A ^d   Poll The, Bwee Tien T ^e,f   Bakker, Henk D ^f   Loonen, M Christa B ^a   De Klerk, Johannis B C ^a   Reuser, Arnold J J ^b   Van der Ploeg, Ans T ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

glucosidase; Acid maltase; Enzyme replacement; Glycogen storage disease type II; Pompe's disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GLUCOSIDASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; GLUCAN 1,4 ALPHA GLUCOSIDASE; LACTATE DEHYDROGENASE;

ARTICLE; AUTOPSY; CLINICAL ARTICLE; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 2; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART WEIGHT; HUMAN; HUMAN TISSUE; INFANT; LIFESPAN; MALE; MORTALITY; MOTOR DEVELOPMENT; NOSE FEEDING; PRIORITY JOURNAL;

ALPHA-GLUCOSIDASES; BLOOD CHEMICAL ANALYSIS; BRAIN; CARDIOMEGALY; CHILD DEVELOPMENT; DISEASE PROGRESSION; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MUTATION; NETHERLANDS; SURVIVAL ANALYSIS;

EID: 0042131675     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.112.2.332     Document Type: Article

References (111)

1. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol. III. New York, NY: McGraw-Hill, 2001:3389-3420
2. Engel AG, Gomez MR, Seybold ME, Lambert EH. The spectrum and diagnosis of acid maltase deficiency. Neurology. 1973;23:95-106
3. Wokke JH, Ausems MG, van den Boogaard MJ, et al. Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol. 1995;38:450-454
4. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr. 2000;137:283-285
5. Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet. 1999;7:713-716
6. Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease [letter]. Am J Med Genet. 1998;79:69-72
7. Van den Hout JM, Reuser AJ, de Klerk JB, Arts WF, Smeitink JA, Van der Ploeg AT. Enzyme therapy for pompe disease with recombinant human α-glucosidase from rabbit milk. J Inherit Metab Dis. 2001;24:266-274
8. Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human α-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356:397-398
9. Amalfitano A, Bengur AR, Morse RP, et al. Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med. 2001;3:132-138
10. Di Sant' Agnese PA, Andersen DH, Howard HM. Glycogen storage disease of the heart II. Critical review of the literature. Pediatrics. 1950;6:607-623
11. Ehlers KH, Hagstrom JWC, Lukas S, Redo SF, Engle MA. Glycogen-storage disease of the myocardium with obstruction to left ventricular outflow. Circulation. 1962;25:96-109
12. Hers HG. α-glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease). Biochem J. 1963;86:11-16
13. Bijvoet AG, Van Hirtum H, Kroos MA, et al. Human acid α-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet. 1999;8:2145-2153
14. Reuser AJ, Koster JF, Hoogeveen A, Galjaard H. Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet. 1978;30:132-143
15. Hermans MM, Kroos MA, Smeitink JA, van der Ploeg AT, Kleijer WJ, Reuser AJ. Glycogen Storage Disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry. Hum Mutat. 1998;11:209-215
16. Reuser AJ, Kroos M, Oude Elferink RP, Tager JM. Defects in synthesis, phosphorylation, and maturation of acid α-glucosidase in glycogenosis type II. J Biol Chem. 1985;260:8336-41
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083
18. Agarwala BN. Pompe's disease in identical twins. Hosp Pract (Off Ed). 1986;21:146-148, 153, 156-158
19. Alday LE, Moreyra E. Secondary hypertrophic cardiomyopathy in infancy and childhood. Am Heart J. 1984;108:996-1000
20. Antopol W, Heilbruinn J, Tuchman L. Enlargement of the heart due to abnormal glycogen storage. In von Gierke disease. Am J Med Sci. 1934;188:354-359
21. Asukata I, Aizawa S, Kosakai M, Kirino Y, Ishikawa E. An autopsy case of type II glycogenosis. Acta Pathol Jpn. 1976;26:629-635
22. von Bassewitz DB, Bremer HJ, Bourgeois M, Grobe H, Stoermer J. Vacuolated lymphocytes in type II glycogenosis - a diagnostic approach? Eur J Pediatr. 1977;127:1-7
23. Ausems MG, Kroos MA, Van der Kraan M, et al. Homozygous deletion of exon 18 leads to degradation of the lysosomal α-glucosidase precursor and to the infantile form of glycogen storage disease type II. Clin Genet. 1996;49:325-328
24. Bharati S, Serratto M, DuBrow I, et al. The conduction system in Pompe's disease. Pediatr Cardiol. 1982;2:25-32
25. Bonnici F, Shapiro R, Joffe HS, Petersen EM. Angiocardiographic and enzyme studies in a patient with type II glycogenosis (Pompe's disease). A case report. S Afr Med J. 1980;58:860-862
26. Bulkley BH, Hutchins GM. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. Am Heart J. 1978;96:246-252
27. Cadell J, Whittemore R. Observations on generalized glycogenosis with emphasis on electrocardiographic changes. Pediatrics. 1962:743-763
28. Chen MR, Lin SP, Loo JH, Sung TC, Chen BF. Pompe's disease: report of a neonatal case. Taiwan Yi Xue Hui Za Zhi. 1988;87:1017-1020
29. Childs AW, Crose RF, Henderson PH. Glycogen disease of the heart. Report of two cases occurring in siblings. Pediatrics. 1952;10:208
30. Clement DH, Godman GC. Glycogen disease resembling mongolism, cretinism and amyotonia congenita; case report and review of literature. J Pediatr. 1950:11-13
31. Coppola A, Munoz A, Sher J. Morphologic changes of lymphocytes in Pompe disease. J Pediatr. 1978;93:824-826
32. Cottrill CM, Johnson GL, Noonan JA. Parental genetic contribution to mode of presentation in Pompe disease. Pediatrics. 1987;79:379-381
33. Crome L, Cumings JN, Duckett S. Neuropathological and neurochemical aspects of generalized glycogen storage disease. J Neurol Neurosurg Psychiat. 1963;26:422-430
34. Di Sant' Agnese PA, Andersen DH, Mason HH, Bauman WA. Glycogen storage disease of the heart I. Report of two cases in siblings with chemical and pathological studies. Ann N Y Acad Sci. 1950;72:402-424
35. Dickinson DF, Houlsby WT, Wilkinson JL. Unusual angiographic appearances of the left ventricle in 2 cases of Pompe's disease (glycogenosis type II). Br Heart J. 1979;41:238-240
36. Friedman S, Ash R. Glycogen storage disease of the heart. Clinical observations in five infants. J Pediatr. 1958;52:635-647
37. Fung KP, Lo RN, Ho HC. Pompe's disease presenting as supraventricular tachycardia. Aust Paediatr J. 1989;25:101-102
38. Garancis JC. Type II glycogenosis. Biochemical and electron microscopic study. Am J Med. 1968;44:289-300
39. Gebhart W, Mainitz M, Jurecka W, et al. [Ichthyosiform scating in α-1, 4-glucosidase deficiency]. Hautarzt. 1988;39:228-232
40. Gitzelman R. Glukagonprobleme bei glykogenspeicherkrankheiten. Helv Paediatr Acta. 1957:425-490
41. Hernandez A Jr, Marchesi V, Goldring D, Kissane J, Hartmann AF Jr. Cardiac glycogenosis. Hemodynamic, angiocardiographic, and electron microscopic findings - report of a case. J Pediatr. 1966;68:400-412
42. Hertz W, E. J Glykogenspeicherkrankheiten unter dem klinischen bilde des myxodems. Z Kinderheilkd. 1936:58-60
43. Hinerman DL. Familial cardiac glycogen storage disease. Arch Path Anat. 1955;331:359-368
44. Hogan GR, Gutmann L, Schmidt R, Gilbert E. Pompe's disease. Neurology. 1969;19:894-900
45. Hohn AR, Lowe CU, Sokal JE. Cardiac problems in the glycogenoses with specific reference to Pompe's disease Pediatrics. 1965:313-321
46. Hui KS, Williams JC, Borit A, Rosenberg HS. The endocrine glands in Pompe's disease. Report of two cases. Arch Pathol Lab Med. 1985;109:921-925
47. Huie ML, Hirschhorn R, Chen AS, Martiniuk F, Zhong N. Mutation at the catalytic site (M519V) in glycogen storage disease type II (Pompe disease). Hum Mutat. 1994;4:291-293
48. Humphreys ME, Kato K. Glycogen storage disease. Am J Pathol. 1934;10:589-617
49. Hwang B, Meng CC, Lin CY, Hsu HC. Clinical analysis of five infants with glycogen storage disease of the heart-Pompe's disease. Jpn Heart J. 1986;27:25-34
50. Jacob JL, Leandro RL, Parro Junior A. Pompe's disease or type IIa glycogenosis. Arq Bras Cardiol. 1999;73:435-440
51. Jean C, Miller G. Glycogenose cardiaque. Presentations anatomique de deux cas. Laval Med. 1960;29:447-456
52. Jeune M, Larbre F, Muller JM, Texier D'Arnoult A. Observation anatomoclinique d'un cas de glycogenose cardiaque diffuse (maladie de Pompe) avec fibroelastosis de l'endocard. Pediatrie. 1959;14:399-407
53. Landing BH, Bangle R. Glycogen storage diseases. I. Familial cardiac glycogen storage diseases: report of two cases and discussion of relation to other forms of abnormal glycogen deposition. J Tech Meth Int A Mes Museums Bull 1950;31:84
54. Landing BH, Villee C, Nadas AS. Cardiac glycogen storage disease: a study of three siblings. Proc New Engl Cardiovasc Soc. 1952-1952:42
55. Langewisch WH, Bigler JA. Disorders of glycogen metabolism. With special reference to glycogen storage disease and galactosemia. Padiatrics. 1952;9:263-279
56. Lee CC, Chen CY, Chou TY, Chen FH, Zimmerman RA. Cerebral MR manifestations of Pompe disease in an infant. AJNR Am J Neuroradiol. 1996;17:321-322
57. Levin S, Moses SW, Chayoth R, Jagoda N, Steinitz K. Glycogen storage disease in Israel. A clinical, biochemical and genetic study. Isr J Med Sci. 1967;3:397-410
58. Lin CY, Shieh JJ. Identification of a de Novo point mutation resulting in infantile form of Pompe's disease. Biochem Biophys Res Commun. 1995;213:367
59. Loonen MC, Busch HF, Koster JF, et al. A family with different clinical forms of acid maltase deficiency (glycogenosis type II): biochemical and genetic studies. Neurology. 1981;31:1209-1216
60. Lorber A, Luder AS. Very early presentation of Pompe's disease and its cross-sectional echocardiographic features. Int J Cardiol. 1987;16:311-314
61. Luck R, Platt D, Lange RH, Kunze K. [Clinical, biochemical, morphological and electrophysiological studies of glycogenosis Type II in childhood with double deficiency of enzymes (author's transl)]. Z Kinderheilkd. 1975;120:19-28
62. Manca A. Sulla ipertrophia di cuore idiopatica congenita. Cuore Circ. 1936;20:513
63. Mancall GB, Aponte GE, Berry RG. Pompe's disease (diffuse glycogenesis) with neuronal storage.
64. Martin JG, Bonte FJ. Glycogen disease. Reports of two cases with cardiomegaly. Am J Roentgenol. 1951;66:922-1951
65. Mazzitello WF, Briggs JF. Glycogen storage disease of the myocardium. Dis Chest. 1957;32:636-645
66. McFarlane HJ, Soni N. Pompe's disease and anaesthesia. Anaesthesia. 1986;41:1219-1224
67. Metzl JD, Elias ER, Berul CI. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease. Pacing Clin Electrophysiol. 1999;22:821-822
68. Monnet P, Larbre F, Gauthier J, Verney R. Glycogenose cardiomusculaire du nourrisson. Essai de determination du trouble enzymatique. Pediatric. 1960;15:60-63
69. Muggia A. Hypertrophie cardiaque congenitale primitive avec stenose pylorique hypertrophyque. Syndrome polycorique par infiltration glycogenique. Rev Franc de Pediat. 1936:774-792
70. Muller OF, Bellet S, Ertrugrul A. Glycogen-storage disease. Report of a case with generalized glycogenosis and review of the literature. Circulation. 1961;23:261-268
71. Mutgeert, BL. Over aangeboren groot hart, speciaal in verband met de glycogeenziekte. Maandschr Kindergeneeskd. 1937;6:233-245
72. Nihill MR, Wilson DS, Hugh-Jones K. Generalized glycogenosis type II (Pompe's disease). Arch Dis Child. 1970;45:122-129
73. Pompe JC. Over idiopathische hypertrophie van het hart. Ned Tijdschr Geneeskd. 1932;76:304-311
74. Putschar W. Uber angeborene Glycogenspeicherkrankheit des Herzens-"Thesaurismosis glycogenica"[v. Gierke]. Beitr Pathol Anat. 1932:222-231
75. Bischoff G. Zum klinischen Bild der Glycogenspeicherkrankheiten. Z Kinderheilkd. 1932:722-726
76. Rees A, Elbl F, Minhas K, Solinger R. Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart). Am J Cardiol. 1976;37:1103-1106
77. Rosen KR, Broadman LM. Anaesthesia for diagnostic muscle biopsy in an infant with Pompe's disease. Can Anaesth Soc J. 1986;33:790-794
78. Rossi E. Herzkrankheiten im saulingsalter. Stuttgart, Germany: Georg Thieme; 1954
79. Ruttenberg HD, Steidl RM, Carey LS, Edwards JE. Glycogen-storage disease of the heart. Hemodynamic and angiocardiographic features in 2 cases. Am Heart J. 1964:469-480
80. Sakurai I, Tosaka A, Mori Y, Imura S, Aoki K. Glycogenosis type II (Pompe). The fourth autopsy case in Japan. Acta Pathol Jpn. 1974;24:829-846
81. Sarnat HB, Roth SI, Carroll JE, Brown BI, Dungan WT. Lipid storage myopathy in infantile Pompe's disease. Arch Neurol. 1982;39:180-183
82. Schnabel R. Uber die neuromuskulare form der glykogenspeicherungskrankheit. Virchows Arch. 1958;331:287-313
83. Seifert BL, Snyder MS, Klein AA, O'Loughlin JE, Magid MS, Engle MA. Development of obstruction to ventricular outflow and impairment of inflow in glycogen storage disease of the heart: serial echocardiographic studies from birth to death at 6 months. Am Heart J. 1992;123:239-242
84. Selberg W. Die glykogenose des sauglings unter dem bilde einder todlich verlaufenden cerbrospinalen erkrankung. Z Kinderhefikd. 1953;72:306-320
85. Sethuraman S, Mahamood M, Krishnanunni S, Rajalakshmi. Glycogen storage disease type II [letter]. Indian Pediatr. 1993;30:1053-1054
86. Shieh JJ, Lin CY. Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II. Biochem Biophys Res Conumm. 1996;219:322-326
87. Sprague HB, Bland EF, White PD. Congenital idiopahic hypertrohy of the heart. Am J Dis Child. 1931;41:877-886
88. Ullrich K, Grobe H, Korinthenberg R, von Bassewitz DB. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia. Pathol Res Pract. 1986;181:627-632
89. Van Creveld S. Investigations on glycogen disease. Dis Child. 1934:9-10
90. Van Creveld S. Glycogen disease. Medicine. 1939;1:1
91. Verity MA. Infantile Pompe's disease, lipid storage, and partial carnifine deficiency. Muscle Nerve. 1991;14:435-440
92. Wachstein M. Glycogen storage of a case with histochemical phosphate studies. Am J Med Sci. 1947;214:401-409
93. Wijburg FA, Rosenblatt DS, Vos GD, et al. Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation. Eur J Pediatr. 1992;151:127-131
94. Willemsen MA, Jira PE, Gabreels FJ, van der Ploeg AT, Smeitink JA. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease]. Ned Tijdschr Geneeskd. 1998;142:1388-1392
95. Wilson RA, Clark N. Endocardial fibroelastosis associated with generalized glycogenosis. Pediatrics. 1960;26:86-96
96. Wolf K. XIV. Beitrag zur Morphologie und chemie der glykogenspeicherkrankheiten. Beitr Pathol Anat. 1936;96:289-306
97. Yamamoto T, Egughi A, Okudaira M, Suzuki E. Glycogen storage disease of the heart. First case in Japan. Am J Cardiol. 1960:556-559
98. Kroos MA, Van der Kraan M, Van Diggelen OP, et al. Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients [letter] [see comments]. J Med Genet. 1995;32:836-837
99. Lin CY, Shieh JJ. Identification of a de novo point mutation resulting in infantile form of Pompe's disease [published erratum appears in Biochem Biophys Res Commun 1995 Aug 4;213:367]. Biochem Biophys Res Commun. 1995;208:886-893
100. Raben N, Nichols RC, Boerkoel C, Plotz P. Genetic defects in patients with glycogenosis type II (acid maltase deficiency). Muscle Nerve. 1995;3:S70-S74
101. Kroos MA, van Leenen D, Verbiest J, Reuser AJ, Hermans MM. Glycogen storage disease type 11: identification of a dinucleotide deletion and a common missense mutation in the lysosomal α-glucosidase gene. Clin Genet. 1998;53:379-382
102. Dagnino F, Stroppiano M, Regis S, Bonuccelli G, Filocamo M. Evidence for a founder effect in Sicilian patients with glycogen storage disease type II. Hum Hered. 2000;50:331-333
103. Martin JJ, Clara R, Ceuterick C, Joris C. Is congenital fibre type disproportion a true myopathy? Acta Neurol Belg. 1976;76:335-344
104. Atkin J, Snow JW Jr, Zellweger H, Rhead WJ. Fatal infantile cardiac glycogenosis without acid maltase deficiency presenting as congenital hydrops [letter]. Eur J Pediatr. 1984;142:150
105. Gussenhoven WJ, Busch HF, Kleijer WJ, de Villeneuve VH. Echocardiographic features in the cardiac type of glycogen storage disease II. Eur Heart J. 1983;4:41-43
106. Huie ML, Chen AS, Brooks SS, Grix A, Hirschhorn R. A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). Hum Mol Genet. 1994;3:1081-1087
107. Mansens BJ. Idiopathische hypertrophic van het hart, diffuse rhabdomyomatose en glycogeenzickte. Maandschr Kindergeneeskd. 1937;6:244-251
108. Bloom KP, Hug G, Schubert WK, Kaplan S. Pompe's disease of the heart. Circulation. 1974;49, 50(Suppl III):III-56
109. Adams EM, Becker JA, Griffith L, Segal A, Plotz PH, Raben N. Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans. Hum Mutat. 1997;10:128-134
110. Hermans MM, De Graaff E, Kroos MA, et al. The effect of a single base pair deletion (δ T525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II. Hum. Mol Genet. 1994;3:2213-2218
111. Boerkoel C, Raben N, Martiniuk F, Miller F, Plotz P. Identification of a deletion common to adult and infantile onset acid α-glucosidase deficiency. Am J Hum Genet. 1992;51:(Suppl):1153-1164